My bookmarksSign up free

Commission Implementing Decision (EU) 2017/1387 of 24 July 2017 authorising the placing on the market of an enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 4975)

Commission Implementing Decision (EU) 2017/1387 of 24 July 2017 authorising the placing on the market of an enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 4975)

Implementing Decision (EU) 2017/1387 · Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Without prejudice to Directive 2002/46/EC, the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger as specified in Annex I to this Decision may be placed on the Union market as a novel food ingredient to be used in food supplements intended for the general adult population with a maximum dose established in Annex II to this Decision.

Article 2

The designation of the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger authorised by this Decision on the labelling of the foodstuffs shall be ‘prolyl oligopeptidase’.

Article 3

This Decision is addressed to DSM Nutritional Products Ltd, Wurmisweg 576, 4303 Kaiseraugst, Switzerland.

Supplementary provisions

ANNEX ISupplementary provisions

ANNEX I Specifications of the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger Specification of the enzyme Systematic name Prolyl oligopeptidase Synonyms Prolyl endopeptidase, proline-specific endopeptidase, endoprolylpeptidase Molecular weight 66 kDa Enzyme Commission number EC 3.4.21.26 CAS number 72162-84-6 Source A genetically modified strain of Aspergillus niger (GEP-44) Description : Prolyl oligopeptidase is available as an enzyme preparation containing approximately 30 % maltodextrin. Specifications of the enzyme preparation of prolyl oligopeptidase Parameter Specifications Limits Activity > 580 000 PPI  ( 1 ) /g (> 34,8 PPU  ( 2 ) /g) Appearance Microgranulate Colour Off-white to orange yellowish. The colour may change from batch to batch Dry Matter > 94 % Gluten < 20 ppm Heavy metals Total heavy metals (as lead) ≤ 10 mg/kg Lead ≤ 1,0 mg/kg Arsenic ≤ 1,0 mg/kg Cadmium ≤ 0,5 mg/kg Mercury ≤ 0,1 mg/kg Microbiological specifications Total aerobic plate count ≤ 10 3 CFU/g Total yeasts and moulds ≤ 10 2 CFU/g Sulphite reducing anaerobes ≤ 30 CFU/g Enterobacteriaceae < 10 CFU/g Salmonella Absent in 25 g Escherichia coli Absent in 25 g Staphylococcus aureus Absent in 10 g Pseudomonas aeruginosa Absent in 10 g Listeria monocytogenes Absent in 25 g Antimicrobial activity Absent Mycotoxins Below limits of detection: Aflatoxin B1, B2, G1, G2 (< 0,25 μg/kg), total Aflatoxins (< 2,0 μg/kg), Ochratoxin A (< 0,20 μg/kg), T-2 Toxin (< 5 μg/kg), Zearalenone (< 2,5 μg/kg), Fumonisin B1 and B2 (< 2,5 μg/kg) ( 1 )   PPI — Protease Picomole International. ( 2 )   PPU — Prolyl Peptidase Units or Proline Protease Units.

ANNEX IISupplementary provisions

ANNEX II Authorised uses of the enzyme preparation of prolyl oligopeptidase produced with a genetically modified strain of Aspergillus niger Food category Maximum dose Food supplements as defined in Directive 2002/46/EC 120 PPU  ( 1 ) /day (2,7 g of enzyme preparation/day) (2 × 10 6 PPI  ( 2 ) /day) for general adult population ( 1 )   PPU — Prolyl Peptidase Units or Proline Protease Units. ( 2 )   PPI — Protease Picomole International.

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next